Navigation Links
The 'bitter' proteins

A new study says that proteins associated with Alzheimer’s may worsen the symptoms of Parkinson’s disease and vice versa, and understanding this interaction could improve treatments for these conditions, say US researchers. Although both diseases are distinct neurological disorders, up to one-third of Alzheimer’s patients develop Parkinson’s and some Parkinson’s patients develop signs of Alzheimer’s.//

To research a possible link between the two diseases, neurology experts from the University of California and Gladstone developed strains of transgenic mice that produce two human proteins – human amyloid precursor protein (hAPP) and human alpha-synuclein (hSYN).Of the two proteins, hAPP is linked with Alzheimer’s and hSYN with Parkinson’s; and mice that produce one of these proteins develop the symptoms of the associated disease.

The researchers discovered that both Alzheimer’s and Parkinson’s symptoms were worse in the mice that had both conditions than in the mice that had just one of the diseases. Alzheimer-like symptoms – degeneration of particular classes of brain cells and impaired ability to learn – were enhanced by the production of hSYN (the protein associated with Parkinson’s), said the team.

They also found that Abeta – a metabolite of the Alzheimer’s protein hAPP – increased the build-up of hSYN in brain cells. This, said the researchers, shows a possible mechanism for the synergistic effects of one of the proteins on the other.The scientists suggest the interaction between the hAPP and hSYN means that drugs blocking these proteins could have broader benefits than previously thought. The study also helps explain the underlying mechanisms that destroy the cognitive and motor functions of Alzheimer’s patients who go on to develop Parkinson’s, they said.


'"/>




Page: 1

Related medicine news :

1. Special proteins to fight TB identified
2. Special proteins to fight TB identified
3. Obese children may have abnormalities of lipoproteins
4. Mix and match of proteins may have a significant role in immunity
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/26/2017)... ... June 26, 2017 , ... KICKICO , a protocol built on ... to solve many catastrophic issues within funding campaigns. KICKICO developers are testing the platform, ... crowdfunding - the raising of funds through the power of many - has been ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... FCPX LUT ... into an old-fashioned vintage look. FCPX LUT Vintage Volume 2 contains 60 different color-grade ... grain for distorted looks, vignettes and blurs to single out subjects, plus much more. ...
(Date:6/25/2017)... , ... June 25, 2017 , ... Republicans in the ... and replace Obamacare, called the Better Care Reconciliation Act. It differs significantly from the ... will need to be reconciled in committee, or the House will have to take ...
(Date:6/25/2017)... (PRWEB) , ... June 25, 2017 , ... CareSet Labs ... in New Orleans. This is a new, greatly improved version of the Doctor ... Act (FOIA) requests by Fred Trotter and subsequently called the the “Doctor Referral Dataset” ...
(Date:6/25/2017)... ... 25, 2017 , ... June is Men’s Health Month and the focus is on ... men in the U.S. and the third most common cause of cancer related death today; ... in seven will be diagnosed with prostate cancer during his lifetime. Those at highest ...
Breaking Medicine News(10 mins):
(Date:6/7/2017)... , June 7, 2017 Endo International plc ... 7, 2017, the Hon. Joseph R. Goodwin , ... West Virginia , entered a case ... Pelvic Repair System Products Liability Litigation (the "MDL") that ... cases to provide expert disclosures on specific causation within ...
(Date:6/3/2017)... -- Eli Lilly and Company (NYSE: LLY ... 3 MONARCH 2 study showed that abemaciclib, a ... with fulvestrant, significantly improved progression-free survival (PFS) compared ... hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative ... progressed after endocrine therapy (median PFS, 16.4 vs. ...
(Date:5/30/2017)... TEL AVIV, Israel , May 30, 2017 /PRNewswire/ ... clinical stage pharmaceutical Company specializing in the development ... management will present a company overview at three ... The 7th Annual LD Micro Invitational: ... Date:                     ...
Breaking Medicine Technology: